MAZathon is on. Save up to 30%* now through November 30, 2025.

Medisca Logo
Login
0
Contact Us
LoginCreate an Account
0
AU FlagEN
Medisca Logo
  • MAZathon
  • Who we serve
  • Products
  • Services
  • Formulas
  • Resources
  • Education
  • About us

Who we serve

  • Pharmacies
  • Cannabis industry
  • Contract manufacturing
  • Hospitals and clinics
  • Laboratory and research
  • Physicians and providers
  • Telehealth
  • Wholesalers

Shop products

  • Promotions
  • Our brands
  • Bases and vehicles
  • Capsules
  • Chemicals
  • Controlled substances
  • Devices
  • Equipment
  • Flavours, colours and oils
  • Lab supplies

Shop services

  • Formulation support
  • Standard operating procedures
  • Specialised consultations
  • Formulation support - free trial

Shop education

  • Education Catalog
  • Self-paced online learning
  • Seminars
  • Webinars
  • Hands-on lab training
  • Provider portals

Formulas & resources

  • Formula library
  • Sample formulas
  • BUDs library
  • Studies library
  • Medisca blog
  • Compounding 101

Customer service

  • Shipping policy
  • Return policy

Company

  • About Medisca
  • Medisca quality
  • Careers
  • Press releases
  • Events

Account

  • Login
  • Create an account

Contact us

  • Customer service
  • 1300 786 392

Who we serve

  • Pharmacies
  • Cannabis industry
  • Contract manufacturing
  • Hospitals and clinics
  • Laboratory and research
  • Physicians and providers
  • Telehealth
  • Wholesalers

Shop products

  • Promotions
  • Our brands
  • Bases and vehicles
  • Capsules
  • Chemicals
  • Controlled substances
  • Devices
  • Equipment
  • Flavours, colours and oils
  • Lab supplies

Shop services

  • Formulation support
  • Standard operating procedures
  • Specialised consultations
  • Formulation support - free trial

Shop education

  • Education Catalog
  • Self-paced online learning
  • Seminars
  • Webinars
  • Hands-on lab training
  • Provider portals

Formulas & resources

  • Formula library
  • Sample formulas
  • BUDs library
  • Studies library
  • Medisca blog
  • Compounding 101

Customer service

  • Shipping policy
  • Return policy

Company

  • About Medisca
  • Medisca quality
  • Careers
  • Press releases
  • Events

Account

  • Login
  • Create an account

Contact us

  • Customer service
  • 1300 786 392

Partners in Wellness

Change region

NABP

Copyright© 1989-

2025 Medisca Inc.
  • Privacy policy
  • Cookie policy
  • Terms & policies
  • Terms of Use
    1. Products
    2. Devices
    3. Syringes & Accessories
    4. Needles & IV Transfer Systems
    5. BD® PhaSeal™ Syringe, Injector, Luer-Lock N35 Safety Device, Sterile
    BD® PhaSeal™ Syringe, Injector, Luer-Lock N35 Safety Device, Sterile

    BD® PhaSeal™ Syringe, Injector, Luer-Lock N35 Safety Device, Sterile

    PhaSeal is a system for the safe handling of hazardous drugs. As a clinically proven closed-system drug transfer device (CSTD), it has been proven to prevent hazardous drug exposure from preparation and administration to waste disposal. The Injector Luer-Lock ensures a closed drug transfer by means of double, elastomeric membranes. The Injector Luer-Lock attaches to a standard syringe or IV tubing for a dry, leak-proof connection during preparation and administration.
    • The only CSTD with extensive third party evidence proving:
    • Prevention of drug exposure
    • Reduction of surface contamination
    • Elimination of human uptake
    • Cutting drug waste to enable savings
    • Protects the microbial state of vial contents*:
    • May reduce impact of drug shortages
    • Helps fund investments in healthcare worker safety
    • May enable better healthcare outcomes
    • Setting the standard in hazardous drug safe handling:
    • Validated by 3rd party studies
    • Utilized by top NCCN and NCI facilities
    • Leading the way:
    • First to obtain ONB clearance
    • First with clearance to prevent microbial ingress
    • First with indications aligned to the NIOSH definition of a CSTD *Data on file at BD
    • The only CSTD with extensive third party evidence proving:
    • Prevention of drug exposure
    • Reduction of surface contamination
    • Elimination of human uptake
    • Cutting drug waste to enable savings
    • Protects the microbial state of vial contents*:
    • May reduce impact of drug shortages
    • Helps fund investments in healthcare worker safety
    • May enable better healthcare outcomes
    • Setting the standard in hazardous drug safe handling:
    • Validated by 3rd party studies
    • Utilized by top NCCN and NCI facilities
    • Leading the way:
    • First to obtain ONB clearance
    • First with clearance to prevent microbial ingress
    • First with indications aligned to the NIOSH definition of a CSTD *Data on file at BD